Physician profile
Barbara J Freeman
NPI 1407955313
$5,679.94
in general payments reported to CMS, 2019-2025
9 companies · $1,493 in 2025
The $1,493 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $883 · 2020: $461 · 2021: $556 · 2022: $305 · 2023: $956 · 2024: $1,026 · 2025: $1,493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,475.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,008.07 | 2019-2025 | Pangea, T2 Alpha, Bio4 |
| Integra Lifesciences Corporation | $711.70 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $327.22 | 2019-2023 | Na, Hammerlock, Spotlight |
| Sanara Medtech INC. | $194.08 | 2023 | Celleraterx |
| Kerecis Limited | $163.64 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Heron Therapeutics, INC. | $125.00 | 2022 | |
| Acumed LLC | $73.68 | 2024-2025 | Innate Implant, Inframe Implant, Acumed |
| Zimmer Biomet Holdings, INC. | $61.27 | 2025 | G7 |
| Kci USA, INC. | $15.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.